Bristol-Myers Squibb Co (NYSE: BMY)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $60.74
-
Support level$54.31
-
Resistance levelN/A
-
Beta0.2
-
RSI (14-day)73.4
- Volatility is forecast to fall over the next month.
- BMY is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, BMY is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $42.60 | $63.11 | 90.3% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $48.85 | $55.16 | $57.04 | $59.32 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.6%
-
In the next month15.7%
-
In the next year56.5%
| Period | Value |
|---|---|
| Historical (5 year) | 23.6% |
| Last month | 28.4% |
| Current estimate | 28.0% |
| Next month forecast | 27.7% |